Clinical Trials Sponsored by Lundbeck Israel

Total 2224 results

Sheba Medical Center
Lundbeck Israel

Unknown

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Major Depressive Disorder

Israel
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Schizophrenia

Israel
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

Escitalopram in Schizophrenia in OCD- Open Label Study

Schizophrenia

Israel
Lundbeck Foundation

Completed

Local Anesthetic in Total Knee Arthroplasty (TKA): Volume Versus Concentration

Postoperative Pain | Analgesic Efficacy

Denmark
Lundbeck LLC

Completed

Safety and Effectiveness of Open-Label Clobazam in Subjects With Lennox-Gastaut Syndrome (LGS)

Lennox-Gastaut Syndrome
Lundbeck Foundation

Completed

Routine Bladder Catheterisation Through Fast-track Hip and Knee Replacement - What Are the Consequences?

Postoperative Urinary Retention

Denmark
Lundbeck LLC

Withdrawn

An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms

Infantile Spasms
Lundbeck LLC

Completed

Clobazam in Patients With Lennox-Gastaut Syndrome

Epilepsy | Epilepsy, Generalized | Seizures

United States, Belarus, India, Australia, Lithuania
Lundbeck LLC

Completed

Clobazam in Subjects With Lennox-Gastaut Syndrome

Epilepsy | Epilepsy, Generalized | Seizures

United States
Lundbeck LLC

Completed

Melperone (an Anti-Psychotic) in Patients With Psychosis Associated With Parkinson's Disease

Psychotic Disorders | Parkinson's Disease

United States, India, Italy
Lundbeck LLC

Completed

A Study of the Pharmacokinetics (PK) and Safety of IV Carbamazepine Relative to Oral Carbamazepine in Adults With Epilepsy

Epilepsy
Lundbeck LLC

Completed

Sabril Patient Registry

Infantile Spasms | Refractory Complex Partial Seizures in Adults
Lundbeck LLC

Completed

A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®)

Adult Refractory Complex Partial Seizures

United States
Lundbeck Canada Inc.

Completed

Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine (AtWoRC)

Major Depressive Disorder

Canada
Lundbeck Canada Inc.

Completed

Bendamustine Hydrochloride (HCl) in Indolent Non-Hodgkin's Lymphoma That Has Progressed During or Following Treatment With a Rituximab Regimen or Previously Untreated Chronic Lymphocytic Leukemia (BENDACT)

Chronic Lymphocytic Leukemia | Indolent Non-Hodgkin's Lymphoma

Canada
H. Lundbeck A/S

Recruiting

A Trial Investigating Lu AF28996 in Healthy Adult Participants

Healthy Participants

United States
H. Lundbeck A/S

Recruiting

A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults

Healthy Participants

China
H. Lundbeck A/S

Recruiting

Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia

United Kingdom
H. Lundbeck A/S

Recruiting

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine (REJOIN)

Migraine

Spain, Italy, Serbia, United States, Argentina, Mexico, Canada, United Kingdom
H. Lundbeck A/S

Completed

Observational Study in Multiple System Atrophy (TALISMAN)

Multiple System Atrophy

China
H. Lundbeck A/S

Completed

Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions

Healthy

China
Rigshospitalet, Denmark
Lundbeck Foundation

Completed

New Reference Values for Intracranial Pressure

Intracranial Pressure

Czechia, Denmark
H. Lundbeck A/S

Active, not recruiting

A Study of Lu AF82422 in Participants With Multiple System Atrophy (AMULET)

Multiple System Atrophy

United States, Japan
H. Lundbeck A/S

Completed

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)

Parkinson Disease

Japan
H. Lundbeck A/S

Completed

Eptinezumab in Participants With Episodic Cluster Headache (ALLEVIATE)

Cluster Headache, Episodic

Spain, United States, Germany, Portugal, Italy, Netherlands, Finland, Belgium, Czechia, Denmark, France, Georgia, Russian Federation, United Kingdom, Greece, Estonia, Japan, Norway, Sweden
H. Lundbeck A/S

Completed

A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments (DELIVER)

Migraine

Spain, United States, Bulgaria, Hungary, Germany, Poland, Georgia, Belgium, Finland, Czechia, Denmark, France, Italy, Russian Federation, Slovakia, Sweden, United Kingdom
H. Lundbeck A/S

Completed

Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease

Healthy | Alzheimer Disease

United States
H. Lundbeck A/S

Completed

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) (CHRONICLE)

Chronic Cluster Headache

Spain, Germany, United Kingdom, United States, Netherlands, Denmark, Finland, France, Italy
H. Lundbeck A/S

Completed

Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)

PTSD

United States
H. Lundbeck A/S

Completed

Safety and Tolerability of Lu AG06474 in Healthy Young Men

Healthy

United States
H. Lundbeck A/S

Terminated

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

Depressive Disorder, Major

United States, Korea, Republic of, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Latvia, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Mexico, South Africa, United Kingdom
H. Lundbeck A/S

Completed

A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines

Healthy Participants

United States
H. Lundbeck A/S

Completed

A Study Investigating Lu AG06466 in Healthy Men

Healthy Volunteers

United Kingdom
H. Lundbeck A/S

Completed

A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects

Healthy

Denmark
H. Lundbeck A/S

Completed

Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

Healthy | Parkinson Disease

United States
Lundbeck Japan K. K.

Completed

Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke (DIAS-J)

Acute Ischemic Stroke

Japan
H. Lundbeck A/S

Completed

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) (RECONNECT)

Anxiety Disorders | MDD

Estonia, France, Italy, Korea, Republic of, Poland, Spain
H. Lundbeck A/S

Completed

Binding of Lu AG06466 in the Brain in Healthy Men

Healthy

Belgium
H. Lundbeck A/S

Completed

An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients

Parkinson Disease

United States
H. Lundbeck A/S

Completed

Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia (Debut)

Schizophrenia

Estonia, Mexico, Russian Federation, Serbia, Ukraine, United States, Bulgaria, Canada, Czechia, Poland, Slovakia, Spain, Romania
H. Lundbeck A/S

Terminated

Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia

Schizophrenia

Bulgaria, Czechia, Estonia, Germany, Hungary, Latvia, Poland, Ukraine
H. Lundbeck A/S

Terminated

Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects

Healthy | Parkinson Disease

France
H. Lundbeck A/S

Completed

Positron Emission Tomography (PET) Study Investigating Dopamine and Serotonin Receptor Occupancy After Multiple Oral Dosing of Lu AF35700

Schizophrenia

United States
H. Lundbeck A/S

Terminated

Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia (Anew)

Treatment-resistant Schizophrenia

United States, Japan, Russian Federation, Bulgaria, United Kingdom
H. Lundbeck A/S

Completed

Study With Lu AF35700 in Healthy Men and Women in Fasting and Fed State

Healthy

United Kingdom
H. Lundbeck A/S

Terminated

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

Renal Failure

Germany
H. Lundbeck A/S

Completed

Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
H. Lundbeck A/S

Completed

Single Ascending Dose Study of Lu AF76432 in Healthy Young Men

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder

Sleep Disturbances
H. Lundbeck A/S

Completed

Study Investigating the Pharmacokinetic Properties of the Drug Lu AF35700 in Subjects With Liver Impairment and in Healthy Subjects

Hepatic Impairment

Germany

3

Subscribe